breast cancer
lipogenesis
peroxisome proliferator-activated receptor gamma (PPARγ), nuclear receptor
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Apr 2021
30 Apr 2021
Historique:
received:
18
03
2021
revised:
09
04
2021
accepted:
11
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
6
5
2021
Statut:
epublish
Résumé
HER2, which is associated with clinically aggressive disease, is overexpressed in 15-20% of breast cancers (BC). The host immune system participates in the therapeutic response of HER2
Identifiants
pubmed: 33946495
pii: cancers13092171
doi: 10.3390/cancers13092171
pmc: PMC8125290
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : P30 CA010815
Pays : United States
Organisme : NIH HHS
ID : R01HL095675
Pays : United States
Organisme : NIH HHS
ID : R01HL133828
Pays : United States
Organisme : NIH HHS
ID : R01CA132115
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133828
Pays : United States
Organisme : NIH HHS
ID : R21CA235139-01
Pays : United States
Organisme : U.S. Department of Defense
ID : W81XWH1810605
Organisme : NIH HHS
ID : F31CA180604
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095675
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211199
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK127738
Pays : United States
Références
Cancer Res. 2014 Dec 1;74(23):7103-14
pubmed: 25452256
Oncotarget. 2014 Sep 15;5(17):7303-15
pubmed: 25229978
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
Chem Rev. 2011 Oct 12;111(10):6321-40
pubmed: 21988241
Cancer Res. 2014 Jan 15;74(2):508-19
pubmed: 24282282
Science. 2014 May 23;344(6186):921-5
pubmed: 24812208
Br J Pharmacol. 2004 Dec;143(8):933-7
pubmed: 15533890
Cancers (Basel). 2019 Nov 20;11(12):
pubmed: 31756933
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19035-9
pubmed: 19858489
Nat Immunol. 2014 Nov;15(11):1026-37
pubmed: 25263125
Cancer Med. 2016 Nov;5(11):3246-3259
pubmed: 27726306
Clin Exp Metastasis. 2015 Jan;32(1):65-72
pubmed: 25511644
Int J Cancer. 2007 Feb 1;120(3):702-13
pubmed: 17096328
Int J Mol Sci. 2018 Jul 24;19(8):
pubmed: 30042333
Science. 1987 Jan 9;235(4785):177-82
pubmed: 3798106
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nat Commun. 2018 Sep 25;9(1):3915
pubmed: 30254368
Front Immunol. 2018 May 08;9:893
pubmed: 29867927
Sensors (Basel). 2017 Nov 13;17(11):
pubmed: 29137200
Cancer Res. 1999 Nov 15;59(22):5671-3
pubmed: 10582681
Cancer Res. 2012 Aug 1;72(15):3839-50
pubmed: 22637726
Nat Immunol. 2014 Aug;15(8):717-26
pubmed: 24952503
Breast Cancer Res. 2014 Jul 24;16(4):411
pubmed: 25056669
Nucl Med Biol. 2006 Oct;33(7):847-54
pubmed: 17045164
Mol Cell. 1999 Jun;3(6):799-804
pubmed: 10394368
Cancer Res. 2009 Dec 15;69(24):9236-44
pubmed: 19934321
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
Nat Rev Drug Discov. 2018 Dec;17(12):887-904
pubmed: 30361552
Genome Biol. 2014;15(12):550
pubmed: 25516281
Genes Dev. 2008 Nov 1;22(21):2941-52
pubmed: 18981473
J Biol Chem. 2012 Sep 7;287(37):31116-25
pubmed: 22822073
BMC Genomics. 2011 Mar 16;12:152
pubmed: 21410980
Ann Oncol. 2018 Jan 1;29(1):170-177
pubmed: 29045543
J Biol Chem. 2002 May 31;277(22):19649-57
pubmed: 11877444
Nat Rev Clin Oncol. 2017 Jan;14(1):11-31
pubmed: 27141887
Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a020768
pubmed: 24691965
Mol Cell Biol. 2002 Apr;22(8):2607-19
pubmed: 11909955
Cancer Res. 2010 Jul 15;70(14):5728-39
pubmed: 20570887
Mol Cancer Res. 2011 Nov;9(11):1449-61
pubmed: 21875931
J Clin Invest. 2000 Feb;105(3):287-92
pubmed: 10675354
Genes Dev. 2017 May 15;31(10):1007-1023
pubmed: 28611190
Cancer Res. 2010 Feb 1;70(3):1141-53
pubmed: 20086179
Oncogene. 2014 Apr 24;33(17):2179-90
pubmed: 23686306
J Immunother Cancer. 2019 Mar 29;7(1):90
pubmed: 30922362
Am J Pathol. 2004 Nov;165(5):1743-53
pubmed: 15509542
Cell. 2010 May 14;141(4):668-81
pubmed: 20451243
Med Phys. 2016 Oct;43(10):5380
pubmed: 27782698
Am J Pathol. 2006 Nov;169(5):1784-801
pubmed: 17071600
Lancet Oncol. 2017 Jan;18(1):52-62
pubmed: 27964843
Nat Rev Immunol. 2010 May;10(5):365-76
pubmed: 20414208
Nat Med. 1998 Sep;4(9):1058-61
pubmed: 9734400
Nat Med. 2013 Oct;19(10):1264-72
pubmed: 24056773
Cancer Res. 2006 Sep 1;66(17):8529-41
pubmed: 16951165
Lancet Oncol. 2017 Dec;18(12):1688-1700
pubmed: 29146401
Ann N Y Acad Sci. 2020 May 22;:
pubmed: 32445205
J Biol Chem. 1999 Mar 19;274(12):7913-22
pubmed: 10075686
Nat Commun. 2018 Jan 2;9(1):21
pubmed: 29295986
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102-6
pubmed: 10339548
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2491-6
pubmed: 22308361
Genesis. 2007 Sep;45(9):593-605
pubmed: 17868096
Mol Cell. 1998 Feb;1(3):465-70
pubmed: 9660931
J Cell Sci. 2010 Oct 1;123(Pt 19):3389-400
pubmed: 20826455
J Clin Oncol. 2015 Mar 1;33(7):701-8
pubmed: 25605861
J Clin Invest. 2005 Dec;115(12):3484-93
pubmed: 16284652
Cell. 2017 Oct 19;171(3):683-695.e18
pubmed: 28988771
Oncotarget. 2012 Mar;3(3):345-56
pubmed: 22538444
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Cancer Res. 2019 Oct 1;79(19):4801-4807
pubmed: 31292161
Cell. 1994 Dec 30;79(7):1147-56
pubmed: 8001151
Cancer Cell. 2019 Jun 10;35(6):885-900.e10
pubmed: 31185212
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6
pubmed: 12370429
Cell Death Dis. 2012 Aug 09;3:e361
pubmed: 22874998
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Med. 1998 Sep;4(9):1053-7
pubmed: 9734399
J Natl Cancer Inst. 2000 Mar 1;92(5):418-23
pubmed: 10699072
Cancer Cell. 2019 Apr 15;35(4):588-602.e10
pubmed: 30930117
Cancer Res. 2003 Jun 15;63(12):3395-402
pubmed: 12810676
Cancer Res. 2006 Oct 15;66(20):9986-94
pubmed: 17047061
Curr Biol. 2020 Mar 23;30(6):R246-R248
pubmed: 32208142
Breast Cancer Res. 2021 Jan 23;23(1):11
pubmed: 33485378
N Engl J Med. 2006 Dec 28;355(26):2733-43
pubmed: 17192538
Dev Cell. 2011 Feb 15;20(2):256-63
pubmed: 21316592
Cancers (Basel). 2020 Jan 20;12(1):
pubmed: 31968663
Cancer Cell. 2018 Jan 8;33(1):60-74.e6
pubmed: 29316433
Biochemistry. 2002 May 28;41(21):6640-50
pubmed: 12022867
J Clin Invest. 2008 Jan;118(1):64-78
pubmed: 18079969
N Engl J Med. 2015 Feb 19;372(8):724-34
pubmed: 25693012
Proc Natl Acad Sci U S A. 2017 May 16;114(20):E3954-E3963
pubmed: 28461481
Cancer Discov. 2015 Jan;5(1):22-4
pubmed: 25583800
N Engl J Med. 2012 Nov 8;367(19):1783-91
pubmed: 23020162
J Cell Biol. 2013 Apr 29;201(3):467-84
pubmed: 23629968
Mol Cell Biol. 2013 Aug;33(16):3354-64
pubmed: 23775123
Int J Biochem Cell Biol. 2009 Nov;41(11):2334-42
pubmed: 19563910
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7438-43
pubmed: 17460049
Cell Stem Cell. 2013 Jul 3;13(1):102-16
pubmed: 23827712
Genes Dev. 2004 Mar 1;18(5):528-40
pubmed: 15037548
Cell Adh Migr. 2014;8(4):294-307
pubmed: 25482632
Nat Rev Cancer. 2007 May;7(5):389-97
pubmed: 17446858
Signal Transduct Target Ther. 2017;2:
pubmed: 29218234
Mol Cell Biol. 2000 Jan;20(2):672-83
pubmed: 10611246
Breast Cancer Res Treat. 2008 Dec;112(3):437-51
pubmed: 18204896
J Clin Invest. 2012 Mar;122(3):833-43
pubmed: 22307325
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7771-6
pubmed: 24825888
Nat Commun. 2019 Jul 1;10(1):2901
pubmed: 31263101
Cancer Treat Rev. 2018 Jun;67:10-20
pubmed: 29751334
Nature. 2016 Dec 22;540(7634):588-592
pubmed: 27974798